Vaccine Information: IPOL (Page 4 of 4)

PRINCIPAL DISPLAY PANEL — 10 Dose Vial Label

10 DOSES
IPV
Poliovirus Vaccine
Inactivated — IPOL®

Dosage: 0.5 mL IM or SC.
Rx only
See enclosed package insert.
Store at 2° to 8°C (35° to 46°F).
DO NOT FREEZE.

US Govt Lic #1724
Mf by: Sanofi Pasteur SA,
Marcy L’Etoile France Dist by: Sanofi Pasteur Inc.

Principal Display Panel -- 10 Dose Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 Dose Vial Package

NDC 49281-860-10
IPV

Poliovirus Vaccine
Inactivated — IPOL®

FOR INTRAMUSCULAR OR SUBCUTANEOUS
ADMINISTRATION.

10 DOSES

Rx only

SANOFI PASTEUR

PRINCIPAL DISPLAY PANEL -- 10 Dose Vial Package
(click image for full-size original)
IPOL poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated) injection, suspension
Product Information
Product Type VACCINE Item Code (Source) NDC:49281-860
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) (POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)) POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U] in 0.5 mL
POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) (POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)) POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) 8 [D'ag'U] in 0.5 mL
POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) (POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)) POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 32 [D'ag'U] in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
PHENOXYETHANOL 3 uL in 0.5 mL
FORMALDEHYDE 20 ug in 0.5 mL
NEOMYCIN 5 ng in 0.5 mL
STREPTOMYCIN 200 ng in 0.5 mL
POLYMYXIN B 25 ng in 0.5 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49281-860-10 1 VIAL, MULTI-DOSE in 1 PACKAGE contains a VIAL, MULTI-DOSE (49281-860-78)
1 NDC:49281-860-78 5 mL in 1 VIAL, MULTI-DOSE This package is contained within the PACKAGE (49281-860-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA103930 12/21/1990
Labeler — Sanofi Pasteur Inc. (086723285)
Establishment
Name Address ID/FEI Operations
Sanofi Pasteur Inc. 578763542 MANUFACTURE

Revised: 01/2020 Sanofi Pasteur Inc.

Page 4 of 4 1 2 3 4

VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Vaccine Sections

Vaccine Information by RSS

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.